Categories | Unadjusted | Multivariate | ||||
OR | CI | P-Value | OR | CI | P-Value | |
Age in years | 1.005 | 0.988 - 1.023 | 0.5518 |
|
|
|
Disease Duration | 1.173 | 1.128 - 1.220 | <0.0001** | 0.989 | 0.861 - 1.135 | 0.8701 |
Diagnosis Duration | 1.162 | 1.118 - 1.207 | <0.0001** | 1.239 | 1.072 - 1.432 | 0.0038** |
Gender | 1.160 | 0.792 - 1.698 | 0.4461 |
|
|
|
Race | 1.071 | 0.626 - 1.833 | 0.8027 |
|
|
|
Education |
| |||||
College | 1.091 | 0.669 - 1.776 | 0.7278 | 0.876 | 0.445 - 1.722 | 0.7000 |
Graduate | 0.650 | 0.376 - 1.125 | 0.1236* | 0.989 | 0.861 - 1.135 | 0.0599* |
Medication Groups |
| |||||
Carbidopa-Levodopa | 1.264 | 0.842 - 1.897 | 0.2576 |
|
|
|
COMT Inhibitors | 1.064 | 0.650 - 1.754 | 0.7969 |
|
|
|
Dopamine Agonists | 1.148 | 0.773 - 1.705 | 0.4945 |
|
|
|
MAO Inhibitors | 1.056 | 0.639 - 1.744 | 0.8308 |
|
|
|
Total Number of Medications | 1.036 | 0.915 - 1.173 | 0.5786 |
|
|
|
Total Number of Medication Groups | 1.081 | 0.915 - 1.278 | 0.3592 |
|
|
|